Exploring Factors in Patient and Family Consideration of Treatment for Pediatric Central Nervous System Tumors
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Central Nervous System Cancer
- Sponsor
- University of Colorado, Denver
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Identify barriers to trial enrollment
- Status
- Recruiting
- Last Updated
- 8 months ago
Overview
Brief Summary
Explore factors involved in decision making for patients with new or recurrent CNS tumors and their families surrounding treatment planning and clinical trial enrollment.
Detailed Description
Explore factors involved in decision making for patients with new or recurrent CNS tumors and their families surrounding treatment planning and clinical trial enrollment. The team will conduct qualitative interviews with a diverse group of patients and families considering treatment for new and recurrent CNS tumors to determine challenges surrounding treatment and study enrollment that may be modifiable through community, hospital, and University of Colorado Cancer Center resources. The team will then assess the impact of these resources on decision making through follow-up interviews.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Be the parent or caregiver of a child or young adult receiving treatment at CHCO
- •a. Child must meet one criterion below: i. Newly diagnosed with a CNS tumor ii. Relapse of a CNS tumor requiring further therapy. Therapy may be standard of care of dictated by an open clinical trial
- •Patient 18 years of age or older a. Must meet one of the criteria below: i. Newly diagnosed with a CNS tumor ii. Relapse of a CNS tumor requiring further therapy. Therapy may be standard of care of dictated by an open clinical trial
Exclusion Criteria
- •Does not meet inclusion criteria
Outcomes
Primary Outcomes
Identify barriers to trial enrollment
Time Frame: 12 months
Qualitative interviews with patients and families who are considering treatment options for new or recurrent CNS tumors to identify specific barriers to full participation in treatment and clinical trial enrollment (e.g., transportation, childcare, ancillary expenses). Qualitative interviews will be structured to comprehensively address potential barriers but also open-ended to give patients and families freedom to discuss a wide range of challenges.